FDA Adverse Event Injury Summary report: N

BARDEX LUBRICATH FOLEY CATHETER

MDR report key: 12107767 · Received July 2, 2021

Report

Report Number
1018233-2021-03991
Event Type
Injury
Date Received
July 2, 2021
Date of Event
June 9, 2021
Report Date
June 16, 2021
Manufacturer
C.R. BARD, INC. (COVINGTON) -1018233
Product Code
EZC
PMA / PMN Number
K910846
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION IS STILL IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETE A SUPPLEMENTAL REPORT WILL BE FILED. THE DEVICE WAS NOT RETURNED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE USER WAS UNABLE TO REMOVE FOLEY CATHETER FOR TRIAL OF VOID DURING POST DEFLATION OF BALLOON. THE USER REMOVED 12ML VIA VALVE AND WAITED ABOUT 10 MINUTES WITH THE SYRINGE ATTACHED TO THE CATHETER VALVE TO SEE IF MORE WATER MIGHT BE DRAINED. THE USER WAS STILL UNABLE TO REMOVE THE FOLEY CATHETER AND FELT PLENTY OF RESISTANCE. PATIENT WAS NOT IN PAIN AND JUST EXPERIENCED URINARY URGENCY. THE DOCTOR TRIED TO REMOVE IT BY THEMSELF BUT WAS STILL NOT ABLE TO REMOVE IT. THE DOCTOR ATTEMPTED TO REMOVE THE CATHETER USING A GUIDE WIRE AND ALSO CUT THE TIP OF THE VALVE BUT STILL THE FOLEY CATHETER STUCK AT THE SAME POINT IN THE URETHRA. THE DOCTOR ARRANGED THE PATIENT TO WENT TO QUICK ACCESS COMPUTING (QXR) TO HAVE AN ULTRASOUND DONE AND NOTICED THAT SOME WATER WAS STILL IN THE BALLOON DUE TO FAULTY VALVE. THE PATIENT WAS UNDER ULTRASOUND GUIDANCE AND THE DOCTOR POPPED THE BALLOON BY FILLING IT WITH WATER. A FLEXIBLE CYSTOSCOPY WAS PERFORMED TO CHECK IF ANY BALLOON RESIDUE WAS LEFT BEHIND AND DOCTOR REMOVED A SIGNIFICANT SIZED PIECE OF RUPTURED BALLOON VIA SCOPE. PATIENT PASSED THE TRIAL OF VOID AND VOIDING WELL WITH MINIMAL POST VOID RESIDUALS (PVR) AND NO DISCOMFORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1006196 BARDEX LUBRICATH FOLEY CATHETER FOLEY CATHETER EZC C.R. BARD, INC. (COVINGTON) -1018233 UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention